Abigail K. Elias
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abigail K. Elias has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ian Francis Musgrave
Adelaide Medical School The University of Adelaide Australia
3 shared publications - John A. Carver
Research School of Chemistry, The Australian National University, Acton, ACT 2601, Australia
3 shared publications Denis Scanlon
School of Chemistry and Physics, The University of Adelaide, South Australia 5005, Australia
1 shared publicationLam H. Ho
School of Chemistry and Physics, The University of Adelaide, Adelaide, SA 5005, Australia
1 shared publication- Mark R. Wilson
School of Science, Faculty of Science, Medicine & Health, Molecular Horizons Research Institute, University of Wollongong, Wollongong, NSW, Australia
1 shared publication - Tara Louise Pukala
The University of Adelaide
1 shared publication
Latest Publications
- Open Access
The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI)
Clusterin is a glycoprotein present at high concentrations in many extracellular fluids, including semen. Its increased expression accompanies disorders associated with extracellular amyloid fibril accumulation such as Alzheimer’s disease. Clusterin is an extracellular molecular chaperone which prevents the misfolding and amorphous and amyloid fibrillar aggregation of a wide variety of unfolding proteins. In semen, amyloid fibrils formed from a 39-amino acid fragment of prostatic acid phosphatase, termed Semen-derived Enhancer of Virus Infection (SEVI), potentiate HIV infectivity. In this study, clusterin potently inhibited the in vitro formation of SEVI fibrils, along with dissociating them. Furthermore, clusterin reduced the toxicity of SEVI to pheochromocytoma-12 cells. In semen, clusterin may play an important role in preventing SEVI amyloid fibril formation, in dissociating SEVI fibrils and in mitigating their enhancement of HIV infection.
Open AccessThe Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI)
Clusterin is a glycoprotein present at high concentrations in many extracellular fluids, including semen. Its increased expression accompanies disorders associated with extracellular amyloid fibril accumulation such as Alzheimer’s disease. Clusterin is an extracellular molecular chaperone which prevents the misfolding and amorphous and amyloid fibrillar aggregation of a wide variety of unfolding proteins. In semen, amyloid fibrils formed from a 39-amino acid fragment of prostatic acid phosphatase, termed Semen-derived Enhancer of Virus Infection (SEVI), potentiate HIV infectivity. In this study, clusterin potently inhibited the in vitro formation of SEVI fibrils, along with dissociating them. Furthermore, clusterin reduced the toxicity of SEVI to pheochromocytoma-12 cells. In semen, clusterin may play an important role in preventing SEVI amyloid fibril formation, in dissociating SEVI fibrils and in mitigating their enhancement of HIV infection.
- Open Access
- 1 November 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 454 (2) , 295-300
Hemin as a generic and potent protein misfolding inhibitor
- 1 November 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 454 (2) , 295-300
Open AccessHemin as a generic and potent protein misfolding inhibitor
- 1 September 2014
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1844 (9) , 1591-1598
SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells
- 1 September 2014
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1844 (9) , 1591-1598
SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells